scholarly journals Physical Therapies for Psychosomatic Symptoms and Quality of Life Induced by Aromatase Inhibitors in Breast Cancer Patients: A Systematic Review and Meta-Analysis

2021 ◽  
Vol 11 ◽  
Author(s):  
Xue-Ying Zhu ◽  
Zhong Li ◽  
Cong Chen ◽  
Ru-Li Feng ◽  
Bai-Ru Cheng ◽  
...  

ObjectiveTo evaluate the effects of Physical Therapies (PTs) on improvement in psychosomatic symptoms and quality of life (QOL) in breast cancer patients.Data SourcesSeven databases (MEDLINE, EMBASE, Cochrane CENTRAL, China National Knowledge Infrastructure, Wangfang, VIP, and China Biology Medicine disc databases) were systematically searched from the database inception through May 18, 2021.Study SelectionRandomized controlled trials (RCTs) which compared acupuncture or exercise with a sham control or usual care for the treatment of aromatase inhibitors (AIs)-related psychosomatic symptoms and QOL.Data Extraction and SynthesisData were screened and extracted independently using predesigned forms. The quality of RCTs was assessed with the Cochrane Handbook for Systematic Reviews of Interventions. The effect size was calculated via random-effects modeling. The quality of evidence was evaluated with the Grading of Recommendations Assessment, Development and Evaluation approach.Main Outcomes and MeasuresThe score of pain was measured with BPI scale and Western Ontario and the McMaster Universities Index (WOMAC) scale. Emotional state was measured with Pittsburgh Sleep Quality Index (PSQI), Hospital Anxiety and Depression Scale (HADS-A), and Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-Fatigue). The QOL score was measured by self-reported measurements, including the Functional Assessment of Cancer Therapy-General (FACT-G) scale and 36-Item Short Form Survey (SF-36) scale.ResultsEleven RCTs (with 830 patients) were included in the systematic review, and data from 10 RCTs (with 798 patients) were used in the meta-analysis. Results showed acupuncture significantly reduced worst pain scores (P < 0.00001, I2 = 83.5%) [SMD = −0.81, 95% CI (−1.51, −0.11)], but the effect of exercise therapies was not significant in overall change in worst pain scores (P =0.006, I2 = 72.3%) [SMD = −0.30, 95% CI (−0.76, 0.16)]. Both acupuncture and exercise resulted in little to no difference in overall change in HADS-A subscale (P = 0.026<0.05, I2 = 79.8%) [WMD = −0.21, 95% CI (−3.44, 3.03)], PSQI subscale (P = 0.488, I2 = 0%) [WMD = 0.98, 95% CI (−0.57, 2.53)], and FACIT-Fatigue subscale (P = 0.022<0.05, I2 = 81.0%) [WMD = 1.6, 95% CI (−5.75, 8.94)]. Exercise (compared with usual care) was associated with improving overall change in health-related QOL (subscales of SF-36 tool) (P = 0, I2 = 72.1%) [WMD = 7.97, 95% CI (5.68, 10.25)] and cancer-specific QOL (subscales of FACT-G tool) (P = 0.304, I2 = 16%) [WMD = 1.16, 95% CI (0.34, 1.97)].Conclusions and RelevanceThis systematic review and meta-analysis suggested that based on moderate-level evidence, acupuncture was associated with significant reductions in pain intensity, and exercise might improve QOL in breast cancer patients treated with AIs. However, in psychosomatic symptoms such as anxiety, sleep disturbance, and fatigue, acupuncture and exercise training did not result in significant improvements.

2018 ◽  
Vol 170 (2) ◽  
pp. 205-212 ◽  
Author(s):  
Salehoddin Bouya ◽  
Maryam koochakzai ◽  
Hosein Rafiemanesh ◽  
Abbas Balouchi ◽  
Safiyeh Taheri ◽  
...  

2021 ◽  
Author(s):  
Teshome Demelash Bitew ◽  
Wondim Ayenew ◽  
Tenaw Baye ◽  
Eskinder Eshetu

Abstract Background Breast cancer remains the most common cancer disease in the world. Higher breast cancer incidence and poor survival is also seen in different African countries. Diagnosed with breast cancer and treatment is a very stressful event that greatly diminished the quality of life of the patient. Therefore, the aim of this review was to assess health related quality of life and its determinants among breast cancer patients in Africa. Methods A systematic search of literatures was conducted from August 10 to September 5, 2020 without limitation of publication year in PubMed, HINARI, Science direct and Google scholar. The review followed PRISMA guidelines. Data were extracted in a well prepared Microsoft excel and exported to open meta-analysis software for analysis. The methodological quality of included studies was assessed based on 14 item modified quality of life assessment checklist. The pooled estimate quality of life scales were analyzed by open Meta analyst software and presented with forest plot. The results of included studies which were not suitable for meta-analysis were synthesized narratively. The heterogeneity of included studies was evaluated with I2 statistics. Results A total of ten studies which reported 2,190 breast cancer patients were included in the systematic review and meta- analysis. This review summarized five different standard instruments that used to measure health related quality of life. The pooled estimates mean score of general quality of life based on EORTC QLQ-C30 standard tool was 52.77 (95% CI: 42.199 to 63.345; I2 = 99.21%, P < 0.001). Age, level of education, marital status and financial difficulties were determinants health related quality of life in breast cancer patients in Africa. Conclusions The general health related quality of life of African breast cancer patients was not good. Therefore, more attention must be paid to the quality of life of breast cancer patients along with proper access to treatment. Protocol registration: The study protocol is registered at PROSPERO with reference ID CRD42020213726 and available at https://www.crd.york.ac.uk/prospero/displayrecord.php?id=crd42020213726


BMJ Open ◽  
2020 ◽  
Vol 10 (5) ◽  
pp. e033461
Author(s):  
Kyeore Bae ◽  
Si Yeon Song

IntroductionAromatase inhibitor-induced arthralgia (AIA) is a major adverse event of aromatase inhibitors (AIs) and leads to premature discontinuation of AI therapy in breast cancer patients. The objective of this protocol for a systematic review and network meta-analysis (NMA) is to provide the methodology to compare the change in pain intensity between different AIA treatments and demonstrate the rank probabilities for different treatments by combining all available direct and indirect evidence.Methods and analysisPubMed, the Cochrane Controlled Register of Trials (CENTRAL), EMBASE, Web of Science and ClinicalTrials.gov will be searched to identify publications in English from inception to November 2019. We will include randomised controlled trials (RCTs) assessing the effects of different treatments for AIA in postmenopausal women with stage 0–III hormone receptor-positive breast cancer. The primary endpoints will be the change in patient-reported pain intensity from baseline to post-treatment. The number of adverse events will be presented as a secondary outcome.Both pairwise meta-analysis and NMA with the Frequentist approach will be conducted. We will demonstrate summary estimates with forest plots in meta-analysis and direct and mixed evidence with a ranking of the treatments as the P-score in NMA. The revised Cochrane risk-of-bias tool for randomised trials will be used to assess the methodological quality within individual RCTs. The quality of evidence will be assessed.Ethics and disseminationAs this review does not involve individual patients, ethical approval is not required. The results of this systematic review and NMA will be published in a peer-reviewed journal. This review will provide valuable information on AIA therapeutic options for clinicians, health practitioners and breast cancer survivors.PROSPERO registration numberCRD42019136967.


2021 ◽  
Vol 32 ◽  
pp. S43-S44
Author(s):  
K.S. Harborg ◽  
R. Zachariae ◽  
J. Olsen ◽  
M. Johannsen ◽  
D. Cronin-Fenton ◽  
...  

Oncotarget ◽  
2016 ◽  
Vol 7 (9) ◽  
pp. 10373-10385 ◽  
Author(s):  
Weige Tan ◽  
Qian Li ◽  
Kai Chen ◽  
Fengxi Su ◽  
Erwei Song ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document